Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yota Murase

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Recent advances in prostate pathology]Toyonori Tsuzuki, Nagako Maeda, Yota Murase
Pathology|October 19, 2020
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomesTaishi Takahara, Yota Murase, Toyonori Tsuzuki
Pathology International|September 30, 2020
The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinomaYota Murase, Hidehiro Iwata, Taishi Takahara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2018
Renal tumors in end-stage renal disease: A comprehensive reviewToyonori Tsuzuki, Hidehiro Iwata, Yota Murase, et al.
International Journal of Clinical Oncology|September 22, 2020
UroVysion<sup>®</sup> predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective studyHidehiro Iwata, Naoto Sassa, Masashi Kato, et al.
American Journal of Clinical Pathology|January 23, 2019
Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary TractNaoto Sassa, Hidehiro Iwata, Masashi Kato, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Recent advances in prostate pathology]Toyonori Tsuzuki, Nagako Maeda, Yota Murase
Pathology|October 19, 2020
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomesTaishi Takahara, Yota Murase, Toyonori Tsuzuki
Pathology International|September 30, 2020
The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinomaYota Murase, Hidehiro Iwata, Taishi Takahara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2018
Renal tumors in end-stage renal disease: A comprehensive reviewToyonori Tsuzuki, Hidehiro Iwata, Yota Murase, et al.
International Journal of Clinical Oncology|September 22, 2020
UroVysion<sup>®</sup> predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective studyHidehiro Iwata, Naoto Sassa, Masashi Kato, et al.
American Journal of Clinical Pathology|January 23, 2019
Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary TractNaoto Sassa, Hidehiro Iwata, Masashi Kato, et al.
Pageof 1